Pathology of hereditary breast cancer
- 1 May 2010
- journal article
- review article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 23, S46-S51
- https://doi.org/10.1038/modpathol.2010.37
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Basal Cytokeratin and Epidermal Growth Factor Receptor Expression Are Not Predictive of BRCA1 Mutation Status in Women With Triple-negative Breast CancersThe American Journal of Surgical Pathology, 2009
- Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX familiesLaboratory Investigation, 2007
- Genome-wide association study identifies novel breast cancer susceptibility lociNature, 2007
- PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility geneNature Genetics, 2006
- BRCA1 dysfunction in sporadic basal-like breast cancerOncogene, 2006
- Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutationsOncogene, 2006
- Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast CancerJAMA, 2006
- Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markersBreast Cancer Research and Treatment, 2005
- Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast CancerJNCI Journal of the National Cancer Institute, 2003
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995